Ataxia-telangiectasia: una revisión desde la etiopatogenia al manejo actual con descripción de casos reportados en Perú

Translated title of the contribution: Ataxia telangiectasia: A review from etiopathogenesis to current management with a description of reported cases in Peru

Ismael Araujo-Aliaga, Franciz Velásquez-Cruz, Wilfor Aguirre-Quispe, Angélica López-Saavedra, Elison Sarapura-Castro, Mario Cornejo-Olivas

Research output: Contribution to journalReview articlepeer-review

Abstract

Ataxia-Telangiectasia (AT) is a rare autosomal recessive disease with multisystemic involvement, characterized by slowly progressive ataxia, variable immunodeficiency with recurrent infections, increased risk of neoplasms with or without oculocutaneous telangiectasias. AT is caused by biallelic pathogenic variants within the ATM gene. Its diagnosis is based on suspicion of a compatible clinical symptomatology, increased levels of alpha-fetoprotein, cerebellar atrophy, and genetic testing. There is no curative treatment for AT and its management is based on supportive and preventive measures of eventual complications and genetic counseling. This review updates the epidemiology, clinical manifestations, diagnosis, and treatment of AT, including a search for cases published in Peru.

Translated title of the contributionAtaxia telangiectasia: A review from etiopathogenesis to current management with a description of reported cases in Peru
Original languageSpanish
Pages (from-to)18-29
Number of pages12
JournalRevista de Neuro-Psiquiatria
Volume86
Issue number1
DOIs
StatePublished - Jan 2023

Fingerprint

Dive into the research topics of 'Ataxia telangiectasia: A review from etiopathogenesis to current management with a description of reported cases in Peru'. Together they form a unique fingerprint.

Cite this